4.7 Review

Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities

期刊

BIOCHEMICAL PHARMACOLOGY
卷 85, 期 5, 页码 629-643

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2012.09.018

关键词

Pim kinases; Cancer targets; Therapeutics; PIM inhibitors; Oncogenes

资金

  1. Foundation for Research in Oncology (FERO)
  2. Fundacio Josep Botet
  3. Spanish Ministry of Science and Innovation [SAF2009-08605]
  4. Consejeria de Ciencia e Innovacion
  5. Consejeria de Salud of the Junta de Andalucia [CTS-6844, PI-0142]

向作者/读者索取更多资源

PIM proteins belong to a family of ser/thr kinases composed of 3 members, PIM1, PIM2 and PIM3, with greatly overlapping functions. PIM kinases are mainly responsible for cell cycle regulation, antiapoptotic activity and the homing and migration of receptor tyrosine kinases mediated via the JAK/STAT pathway. PIM kinases have been found to be upregulated in many hematological malignancies and solid tumors. Although these kinases have been described as weak oncogenes, they are heavily targeted for anticancer drug discovery. The present review summarizes the discoveries made to date regarding PIM kinases as driving oncogenes in the process of tumorigenesis and their validation as drug targets. (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据